Skip to content

F.C.N.: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

F.C.N.

BE 0877.237.910
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€3,895
2024 · -€5,796+€1,902
Equity
-€49,833
2024 · -€45,938-€3,895
Cash
€11
2024 · €69-€58
Balance sheet total
€1,101
2024 · €1,159-€58

Largest movements

2024 to 2025
Assets
  • Cash -€58

    down €58 (-84.2%), from €69 to €11

    mainly Net result for the year (-€3,895)

Equity and liabilities
  • Profit (loss) carried forward -€3,895

    down €3,895 (-5.9%), from -€66,398 to -€70,293

  • Tax, wage and social debts +€2,500

    up €2,500 (+396.9%), from €630 to €3,130

    of which Taxes: +€2,500

  • Trade debts +€796

    up €796 (+26.3%), from €3,025 to €3,821

  • Other debts +€540

    up €540 (+1.2%), from €43,442 to €43,982

Income statement
  • Financial charges -€1,856

    down €1,856 (-93.9%), from €1,977 to €121

  • Other operating charges +€413

    up €413 (+12.3%), from €3,361 to €3,774

  • Taxes -€258

    down €258 (-100.0%), from €258 to €0

  • Gross operating margin +€200

    no longer reported in 2025 (was -€200)

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€5,796
Other operating charges -€413
Other operating items +€200
Financial income +€0
Financial charges +€1,856
Taxes +€258
Result 2025 -€3,895

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€58
Investment €0
Financing €0
Cash 2024 €69
Net result for the year -€3,895
Trade debts +€796
Tax, wage and social debts +€2,500
Other debts +€540
Cash 2025 €11
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,159 €1,101 -€58 -5.0%
Current assets 29/58 €1,159 €1,101 -€58 -5.0%
Amounts receivable within one year 40/41 €1,090 €1,090 = 0.0%
Trade receivables 40 €1,090 €1,090 = 0.0%
Cash at bank and in hand 54/58 €69 €11 -€58 -84.2%
Total equity and liabilities 10/49 €1,159 €1,101 -€58 -5.0%
Equity 10/15 -€45,938 -€49,833 -€3,895 -8.5%
Contributions 10/11 €18,600 €18,600 = 0.0%
Capital 10 €18,600 €18,600 = 0.0%
Issued capital 100 €18,600 €18,600 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Legal reserve 130 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 -€66,398 -€70,293 -€3,895 -5.9%
Amounts payable 17/49 €47,097 €50,934 +€3,836 +8.1%
Amounts payable within one year 42/48 €47,097 €50,934 +€3,836 +8.1%
Trade debts 44 €3,025 €3,821 +€796 +26.3%
Suppliers 440/4 €3,025 €3,821 +€796 +26.3%
Taxes, remuneration and social security 45 €630 €3,130 +€2,500 +396.9%
Taxes 450/3 - €2,500 +€2,500
Remuneration and social security 454/9 €630 €630 = 0.0%
Other amounts payable 47/48 €43,442 €43,982 +€540 +1.2%
Other operating charges 640/8 €3,361 €3,774 +€413 +12.3%
Gross operating margin 9900 -€200 - +€200
Operating profit (loss) 9901 -€3,561 -€3,774 -€213 -6.0%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €1,977 €121 -€1,856 -93.9%
Recurring financial charges 65 €1,977 €121 -€1,856 -93.9%
Profit (loss) for the period before taxes 9903 -€5,538 -€3,895 +€1,643 +29.7%
Income taxes 67/77 €258 €0 -€258 -100.0%
Profit (loss) for the period 9904 -€5,796 -€3,895 +€1,902 +32.8%
Profit (loss) for the period to be appropriated 9905 -€5,796 -€3,895 +€1,902 +32.8%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.